EXCEED THE SPACE PROVIDED. _ _ ^^ _ _ ___ _ i The long-range goal of the proposed research is to define the structural elements that comprise the outward-facing, water accessible i ; surface of the CFTR chloride channel and are components of the anion-conducting pore, the gating machinery or both; and to ! incorporate this information into a physically-based model for CFTR channel function that will provide the scientific basis for j designing strategies to enhance or attenuate channel function. Understanding the channel function of CFTR will provide insights into ' three devastating diseases; cystic fibrosis (CF), the most effect common fatal inherited disease in the Caucasian population, secretory ; diarrhea, the leading cause of infant mortality worldwide and polycystic kidney disease. It is thought that at least some of the i membrane-spanning segments (TM's) of CFTR contribute to the formation of the anion-selective conduction path, but little is known 1 about the physical basis for conduction, i.e. the anion-channel interactions that govern anion permeability and binding. In addition, i j altered function in mutant CFTRs indicates that at least some of the TMs may be integral parts of the gating machinery. The role of specific residues or groups of residues in conduction and gating is unknown, and identification of these sites would provide data j critical to the design of high conductance pores or ligands that interact with the pore or the gating machinery or both. We propose to | identify residues and/or TMs that comprise the pore by means of covalent labeling coupled with detailed functional analysis, i j Extensive preliminary data demonstrates that it is possible to covalently label cysteines engineered into the outward-facing surface of i i CFTR, and we propose criteria for identifying, among these, 'pore-lining' residues based on the detailed analysis of the impact of ! charge deposition on anion conduction.
The specific aims are: 1. To identify, by covalent labeling of engineered cysteines, residues j ; that lie on the outward-facing, water-accessible surface of CFTR. 2. To investigate the mechanisms by which covalent and non ; i covalent modification of engineered cysteines alters the conduction and gating properties of CFTR and thereby, to identify residues I that are likely to lie within the pore or contribute to the gating machinery, or both. 3. To identify locations in the protein where j | engineered cysteines exhibit conformation-dependent accessibility to polar thiol reagents as a function of either mutation-induced changes in channel structure or changes in the gating state of the channel; that may be points at which a covalent or non covalent modification can 'switch' the protein from one state to another. 4.To test a dielectric stabilization model for permeation by altering the electrostatic environment within the pore by means of helix substitutions or mutations at locations identified by covalent labeling to be 'pore-lining'. We will incorporate the results of these proposed studies into an evolving model for CFTR as a polarizable tunnel with an outer vestibule that functions to concentrate permeant anions in the vicinity of an inner, rate-limiting barrier. j i __ _ _.. . _ . __ . , PERFORMANCE SITE ========================================Section End===========================================

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK045880-13
Application #
6836434
Study Section
General Medicine B Study Section (GMB)
Program Officer
Mckeon, Catherine T
Project Start
1992-09-30
Project End
2006-12-31
Budget Start
2005-01-01
Budget End
2005-12-31
Support Year
13
Fiscal Year
2005
Total Cost
$332,200
Indirect Cost
Name
Oregon Health and Science University
Department
Physiology
Type
Schools of Medicine
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Moran, A R; Norimatsu, Y; Dawson, D C et al. (2014) Aqueous cigarette smoke extract induces a voltage-dependent inhibition of CFTR expressed in Xenopus oocytes. Am J Physiol Lung Cell Mol Physiol 306:L284-91
Liu, Xuehong; Dawson, David C (2014) Cystic fibrosis transmembrane conductance regulator (CFTR) potentiators protect G551D but not ?F508 CFTR from thermal instability. Biochemistry 53:5613-8
Norimatsu, Yohei; Ivetac, Anthony; Alexander, Christopher et al. (2012) Cystic fibrosis transmembrane conductance regulator: a molecular model defines the architecture of the anion conduction path and locates a ""bottleneck"" in the pore. Biochemistry 51:2199-212
Norimatsu, Yohei; Ivetac, Anthony; Alexander, Christopher et al. (2012) Locating a plausible binding site for an open-channel blocker, GlyH-101, in the pore of the cystic fibrosis transmembrane conductance regulator. Mol Pharmacol 82:1042-55
Liu, Xuehong; O'Donnell, Nicolette; Landstrom, Allison et al. (2012) Thermal instability of ýýF508 cystic fibrosis transmembrane conductance regulator (CFTR) channel function: protection by single suppressor mutations and inhibiting channel activity. Biochemistry 51:5113-24
Norimatsu, Yohei; Moran, Aurelia R; MacDonald, Kelvin D (2012) Lubiprostone activates CFTR, but not ClC-2, via the prostaglandin receptor (EP(4)). Biochem Biophys Res Commun 426:374-9
Liu, Xuehong; Dawson, David C (2011) Cystic fibrosis transmembrane conductance regulator: temperature-dependent cysteine reactivity suggests different stable conformers of the conduction pathway. Biochemistry 50:10311-7
Alexander, Christopher; Ivetac, Anthony; Liu, Xuehong et al. (2009) Cystic fibrosis transmembrane conductance regulator: using differential reactivity toward channel-permeant and channel-impermeant thiol-reactive probes to test a molecular model for the pore. Biochemistry 48:10078-88
Liu, Xuehong; Alexander, Christopher; Serrano, Jose et al. (2006) Variable reactivity of an engineered cysteine at position 338 in cystic fibrosis transmembrane conductance regulator reflects different chemical states of the thiol. J Biol Chem 281:8275-85
Weber, Gerhard J; Mehr, Ali Poyan; Sirota, Jeffrey C et al. (2006) Mercury and zinc differentially inhibit shark and human CFTR orthologues: involvement of shark cysteine 102. Am J Physiol Cell Physiol 290:C793-801

Showing the most recent 10 out of 21 publications